Acura Pharmaceuticals
ACUR
ACUR was delisted on the 22nd of February, 2017.
3 hedge funds and large institutions have $1.18M invested in Acura Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 17 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
56% less capital invested
Capital invested by funds: $2.69M → $1.18M (-$1.52M)
86% less funds holding
Funds holding: 22 → 3 (-19)
97% less call options, than puts
Call options by funds: $1K | Put options by funds: $37K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 17
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$786K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$150K |
| 3 |
Renaissance Technologies
New York
|
-$87K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$79K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$34K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EWM
1
Essex Woodlands Management
The Woodlands,
Texas
| $1.18M | – | – | – |
|
|
DM
2
Deerfield Management
New York
| – | -$786K | -1,025,641 | Closed |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| – | -$150K | -195,943 | Closed |
|
|
4
Renaissance Technologies
New York
| – | -$87K | -113,220 | Closed |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| – | -$79K | -103,444 | Closed |
|
|
VKH
6
Virtu KCG Holdings
New York
| – | -$34K | -44,565 | Closed |
|
7
Geode Capital Management
Boston,
Massachusetts
| – | -$16K | -21,129 | Closed |
|
|
FWP
8
FAS Wealth Partners
Leawood,
Kansas
| – | -$13K | -16,396 | Closed |
|
9
Northern Trust
Chicago,
Illinois
| – | -$10K | -12,953 | Closed |
|
10
Morgan Stanley
New York
| – | -$1K | -1,440 | Closed |
|
|
AP
11
Atwood & Palmer
Kansas City,
Missouri
| – | -$1K | -1,010 | Closed |
|
12
Group One Trading
Chicago,
Illinois
| – | -$1K | -807 | Closed |
|
ACUR Hedge Fund Activity: Q1 2017 in Review
3 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q1 2017, worth a combined $1.18M — down 56% from $2.69M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ACUR and 0 opened new positions — a net loss of 17 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Deerfield Management, exiting entirely with an estimated $786K sold.
- 3 institutional investors held Acura Pharmaceuticals (ACUR) as of Q1 2017, down from 22 in Q4 2016.
- Funds reported $1.18M of Acura Pharmaceuticals stock for Q1 2017, down 56% quarter-over-quarter.
- 0 funds opened new Acura Pharmaceuticals positions in Q1 2017 and 17 closed out, a net change of -17 holders.
- The largest Acura Pharmaceuticals seller in Q1 2017 was Deerfield Management, an estimated $786K sold.
Based on aggregated 13F filings for Q1 2017.